BAX and osteosarcoma: Hence, we hypothesized that in osteosarcoma cells, treatment with TMS likely triggers Bax/PUMA/P53 signaling that contributes to intrinsic apoptosis, while cotreatment with TRAIL and TMS likely induces extrinsic apoptosis.